))
Now What? Assessing and Pivoting in the Face of Biologic "Failure"
Manage episode 395752342 series 3466760
Content provided by Dermatology Education Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dermatology Education Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
What’s the difference between primary and secondary failure of a biologic? And why does it matter? Exploring an actual patient case, faculty from the DEF Biologic and Small Molecule NP/PA CME Bootcamp—April Armstrong, MD, MPH; David E. Cohen, MD, MPH; Kara Gooding, MMS, PA-C; and Joe Gorelick, MSN, FNP-C—address these questions and many more. Plus, Mary Beth Hagan, Founder of TITAN Aesthetic Recruiting, gives tips for PAs and NPs interested in cosmetic dermatology, and there are changes coming to iPLEDGE for isotretinoin.
Like what you're hearing? Have a topic you want to hear more about? Hit us up and spread the word on Instagram!
18 episodes
Share
